March 27, 2018 - 5:30 pm — 7:00 pm
369 Link Hall
Please join us for an Engineering Meets Business presentation by Matthew Lyons ’86, the founder and CEO of Blue Slate.
To attend, please register by March 23.
Lyon’s appearance at Syracuse University is part of the ongoing Engineering Meets Business lecture series made possible by a gift from Muss Akram ‘10.
About Matthew Lyons
Lyons is the founder and CEO of Blue Slate, a private business development company focused on creating value for ideas and opportunities in high-growth medical markets.
Lyons has over twenty years of experience in the medical device industry. Graduating from Syracuse University in 1986 with a mechanical engineering degree and specializing in biomechanics, he has held several positions with medical implant companies and holds numerous orthopedic and medical device patents.
In 1986, Lyons was a development engineer with Osteonics Corp, now known as Stryker Orthopedics where he contributed to the company’s total hip group. Lyons joined Exactech Inc. in 1989 as its first engineering manager for the starting orthopedics company. While there, he developed the company’s first porous coated total hip system. Along with product development, Lyons was responsible for establishing many of the company’s operating systems in quality control, regulatory, and manufacturing engineering.
By the early 1990s Lyons rejoined his brother, William Lyons III, as vice president of their family’s orthopedic manufacturing business. Mr. Lyons helped the business his father founded to become a leader in endoscopic instrument development and orthopedic implant manufacturing until it was acquired by Image Guided Systems.
In 1996, Lyons cofounded Blackstone Medical, Inc., as president and CEO, he grew the company’s sales from zero to $92 million in less than ten years, until it was acquired by Orthofix International. In that time, the company introduced over twenty instrument and implant systems, in Class I, II, and III, throughout the US and in over thirty countries around the world.
He is a current member of the Syracuse Biomaterials Institute Advisory Board and the College of Engineering and Computer Science Dean’s Leadership Council